BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the 23rd Annual Needham Virtual Growth Conference on Monday, January 11, 2021, at 11:30 AM ET.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Winter 2021 Investor Conference on Thursday, January 14, 2021, at 10:45 AM ET.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
CONTACT: Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686 smillar@lemaitre.com
Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…
CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment…
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…
Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…